Novartis Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Novartis Korea Co Ltd (NKC), a subsidiary of Novartis AG is a drug developer that offers tumor care drugs. The companys product categories comprise diabetes solvents, malignant tumor, best emetic, antiemetics, general inspection for reagents, smoking cessation aids, antihypertensive, antidote, parasitic skin disease solvent, chemotherapeutic agents and atherosclerosis, among others. It also offers diagnosis and treatment of other tissue cells, skeletal muscle relaxants, thyroid, parathyroid hormone, ophthalmology solvents, non-specific immuno suppressants, analgesic, anti-inflammatory drugs, metabolic drugs, rain and solvents, and cough mixtures. The company develops drugs in the therapeutic areas of cardiovascular diseases, respiratory diseases, central nervous system diseases, eye diseases, cancer, transplantation immunity and skin diseases. NKC is headquartered in Seoul, South Korea.
Novartis Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Novartis Korea Co Ltd (NKC), a subsidiary of Novartis AG is a drug developer that offers tumor care drugs. The companys product categories comprise diabetes solvents, malignant tumor, best emetic, antiemetics, general inspection for reagents, smoking cessation aids, antihypertensive, antidote, parasitic skin disease solvent, chemotherapeutic agents and atherosclerosis, among others. It also offers diagnosis and treatment of other tissue cells, skeletal muscle relaxants, thyroid, parathyroid hormone, ophthalmology solvents, non-specific immuno suppressants, analgesic, anti-inflammatory drugs, metabolic drugs, rain and solvents, and cough mixtures. The company develops drugs in the therapeutic areas of cardiovascular diseases, respiratory diseases, central nervous system diseases, eye diseases, cancer, transplantation immunity and skin diseases. NKC is headquartered in Seoul, South Korea.
Novartis Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
3
List of Tables 4
List of Figures 4
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hanmi Pharma Enters into Co-Marketing Agreement with Novartis Korea 10
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 11
Hyundai Pharma Enters Into Co-Marketing Agreement With Novartis Korea 12
Novartis Korea Co Ltd - Key Competitors 13
Novartis Korea Co Ltd - Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Aug 12, 2016: 6 Novartis Korean executives indicted for bribing doctors 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16
List Of Tables
List of TablesNovartis Korea Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novartis Korea Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Novartis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Hanmi Pharma Enters into Co-Marketing Agreement with Novartis Korea 10
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 11
Hyundai Pharma Enters Into Co-Marketing Agreement With Novartis Korea 12
Novartis Korea Co Ltd, Key Competitors 13
RELATED REPORTS
Novartis Full Year Operating Financial
Novartis 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the Competitive
View ReportNovartis 2023 Third Quarter Operating and Financial Review
Novartis 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the Competitive
View ReportSouth Korea Coagulation Testing Shares Competitive
2024 South Korea Coagulation Testing Market Shares--Competitive Analysis of Leading and Emerging Market Players This new report provides coagulation testing market shares.The report analyzes current and emerging suppliers of coagulation
View Report2024 South Korea Coagulation Testing Market
2024 South Korea Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
